Press releases
- Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
- Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
- Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
- Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024
- Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference
More ▼
Key statistics
On Thursday, Bio Rad Laboratories Inc (BUWA:DUS) closed at 320.60, 30.43% above the 52 week low of 245.80 set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 320.60 |
---|---|
High | 321.80 |
Low | 318.80 |
Bid | -- |
Offer | -- |
Previous close | 319.40 |
Average volume | 2.10 |
---|---|
Shares outstanding | 28.52m |
Free float | 19.98m |
P/E (TTM) | -- |
Market cap | 9.79bn USD |
EPS (TTM) | -21.49 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 18:30 BST.
More ▼